Imaging for diagnosis of Marchiafava-Bignami disease
Sir, I read the two recent publications on imaging for the diagnosis of Marchiafava-Bignami disease (MBD) with great interest. [1, 2] Both the reports showed success in the use of high technology neuro imaging in the diagnosis of MBD. However, whether the new imaging approach is an actually good diagnostic approach for MBD is still questionable. The sensitivity and specificity of the test has to be assessed. Indeed, due to the nature of imaging technology, not a pathological examination, the definitive diagnosis cannot be expected. Indeed, the difference in the details of imaging findings in both the reports can be seen and can be a good supportive evidence for this argument. [1, 2] Second, the MBD is an extremely rare disease, using of imaging technology as a screening cannot be cost effective at all. The use of good clinical practice, good history taking and physical examination, might provide similar outcome of case management since most cases of MBD are usually suspected at rather late stages.
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Neurosyphilis
Sir, I enjoyed reading the editorial l [1] and the two articles [2, 3] on neurosyphilis which appeared in the May-June issue of Neurology India 2009. We have published one of the largest series, 132 patients with neurosyphilis, from India [4] and also on neurosyphilis-related stroke. [5] In this context I would like to make some observations. Neurosyphilis is considered an 'arch simulator' and is to be considered in the differential diagnosis of any lesion involving any component of the neuroaxis. With the emergence of human immunodeficiency virus (HIV) infection, tertiary neurosyphilis is being diagnosed more in the younger ages. We need more diagnostic skills so as not to miss the diagnosis of any type of neurosyphilis; and
